Tevra Brands LLC v. Bayer HealthCare LLC
- Beth Freeman
- 5:19-cv-04312
- U.S. District Court · Northern District of California
- 4
In Tevra Brands v. Bayer HealthCare, Judge Freeman granted both motions to seal narrowly identified transcript portions containing confidential business information.
Tevra Brands LLC and Bayer HealthCare LLC, whose identified transcript portions were ordered sealed; the ruling also limits public access to those portions.
What happened
Tevra Brands LLC v. Bayer HealthCare LLC involved two joint requests to keep selected portions of hearing transcripts from public view. The transcripts came from a March 21, 2024 summary-judgment hearing and an April 18, 2024 hearing about expert testimony.
Bayer HealthCare LLC said disclosure could reveal its business arrangements, retailer agreements, license agreements, and competitive strategies. Tevra said disclosure could reveal its pricing arrangements, sales data, and market-share estimates. Both sides argued that the requested sealing was limited to specific portions.
Judge Beth Labson Freeman granted both administrative motions. The court found compelling reasons to seal the identified portions because they contained confidential and competitively sensitive business information, and it found the requests narrowly tailored.
The detailed version
- Tevra Brands LLC v. Bayer HealthCare LLC · No. 5:19-cv-04312
- Beth Freeman
- May 6, 2024
Background
The court considered two joint administrative motions to file portions of hearing transcripts under seal: ECF No. 334, concerning selected portions of the March 21, 2024 summary-judgment hearing transcript, and ECF No. 336, concerning selected portions of the April 18, 2024 hearing on expert testimony.
Legal standard
The court explained that judicial records generally carry a strong presumption of public access. For records related more than tangentially to the merits of a case, a party seeking a seal must show compelling reasons that outweigh the public’s interest in disclosure. The court also noted that confidential business information, including business strategies, may qualify for sealing when the request is narrowly tailored.
Court’s analysis
For ECF No. 334, the court found compelling reasons to seal the highlighted portions of the March 21 transcript. The portions concerning Bayer contained confidential and competitively sensitive information about Bayer’s retailer agreements and the identities of retailers with which Bayer contracts. The portions concerning Tevra contained confidential and competitively sensitive information about Tevra’s pricing arrangements.
For ECF No. 336, the court found compelling reasons to seal the highlighted portions of the April 18 transcript. The portions concerning Bayer contained confidential and competitively sensitive information about Bayer’s retailer and license agreements. The portions concerning Tevra contained highly confidential information about Tevra’s unit sales data and percentage estimates of its market share based on confidential past sales data.
The court found both sealing requests narrowly tailored to the identified transcript portions.
Disposition
The court ordered that ECF No. 334 is GRANTED and ECF No. 336 is GRANTED.
Read the full 4-page opinion on CourtListener, the free public archive maintained by the Free Law Project.